1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
| {
| "batch_id": "BATCH-STOCK-VALUATION-QINGFENGPU-TIMELINE-20260825-001",
| "ticker": "688046.SH",
| "company": "药康生物",
| "as_of": "2026-08-25",
| "v2_status": "BLOCKED",
| "v2_failure": {
| "complete": false,
| "error": "SourceContractError: 网络请求失败：Remote end closed connection without response",
| "error_code": "E_CORE_INPUT",
| "error_type": "CoreInputError",
| "recorded_at": "2026-08-25T19:57:24.653+08:00",
| "rollback_errors": [],
| "run_id": "52f2c6974124444ab323c5d08bfbb430",
| "schema_version": 2,
| "status": "BLOCKED"
| },
| "v2_runtime_package": "v2_688046_SH.failed-52f2c6974124444ab323c5d08bfbb430",
| "v2_raw_artifact_hashes": [
| "11d5931cae9d83eeddec8710e8b8cf697ca3028fd47b65afec62bebbd0c5570a",
| "1f54b196fbe2429599f40c82e755fdeb2b48bf75e9738c49d86c5d5172a4880a",
| "2f75ed4f4179f5f928be86032d3ddc68987d2579640f73844fb021d00916fc57",
| "413af0210019115c151126e026a575b5c7f40fcc46c025983a46ea5b2f841054",
| "43b21ab11b3aab224b7294b80bda9d1bb896f4743c81f993304fad149daa7489",
| "8a29326a12141a0b69d7e43cfb37c54277f8d46e426b8fe6de2753cfa5734a77",
| "a02b976e06f4e4d6d4e1526a3085c830769a17fea2bbd665d08170014a1d11c0",
| "a8a958df2c207bccf16e5bb261884ddb1fcd8c751f47e9f51df4abe7f0711792"
| ],
| "market_contract": {
| "table": "trading_xuntou.cn_stock_kline_1d_front",
| "source": "xtquant",
| "source_batch_id": "FKL_20260825_161021_6bd1f63d_1d_20260825_00016",
| "updated_at": "2026-08-25 16:39:20",
| "trade_date": "2026-08-25"
| },
| "quote_raw_hash": "",
| "share_proof": {
| "shares": 410000000.0,
| "shares_fallback": true,
| "shares_fallback_source": "statutory_report:report_shares",
| "report_shares": 410000000.0,
| "share_unit_correction": null,
| "static_total_shares": 410000000.0,
| "match_report": true,
| "quote_market_cap": null,
| "price_times_shares": 14140900000.0,
| "gap_rate": 0.0
| },
| "industry_membership": {
| "industries": [
| "医药"
| ],
| "layers": [
| "reverse:医药、创新药与疫苗",
| "timeline"
| ],
| "research_name": "药康生物"
| },
| "bounded_gaps": [
| "V2 quote f124=0，端到端流程诚实阻断；正式估值用当前总股本/市值勾稽，股本历史日期无A1完全匹配时显式保留缺口。",
| "机构汇总缺逐家报告日期与明细，不把一致预期写成法定事实。"
| ],
| "checks": {
| "v1_qa": {
| "error_count": 0,
| "info_count": 0,
| "issues": [],
| "status": "PASS",
| "warning_count": 0
| },
| "label": "明显偏贵",
| "base_low": 6.54264,
| "base_high": 16.4964,
| "optimistic_high": 31.8710448,
| "price": 34.49,
| "bubble_status": "泡沫-极端"
| }
| }
|
|
